AbbVie Inc. is 54.7x more valuable than Alkermes plc. by market capitalization ($399.47 B vs $7.31 B). Every figure below comes from audited SEC filings and refreshed market data.
| Metric | ALKS | ABBV |
|---|---|---|
| Market cap | $7.31 B | $399.47 B |
| US-listed rank | #1122 | #28 |
| Revenue (latest FY) | $1.48B | $61.16B |
| Net income (latest FY) | $241.70M | $4.23B |
| Net margin | 16.4% | 6.9% |
| P/E (trailing FY) | 30.2 | 94.5 |
| SEC filings | 1,884 | 1,008 |
AbbVie Inc. is 54.7x more valuable than Alkermes plc. by market capitalization ($399.47 B vs $7.31 B).
In their latest fiscal years, Alkermes plc. reported $1.48B in revenue while AbbVie Inc. reported $61.16B.
Full pages: Alkermes plc. and AbbVie Inc., or browse the full rankings.